We serve Chemical Name:UNII:8K2S58736F CAS:81925-81-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:UNII:8K2S58736F
CAS.NO:81925-81-7
Synonyms:UNII:8K2S58736F;2-Hepten-4-one, 5-methyl-, (2E)-;5-methyl-2-hepten-4-one;(2E)-5-Methyl-2-hepten-4-one;2Y1&V1U2 &&E Form;MFCD00792509
Molecular Formula:C8H14O
Molecular Weight:126.196
HS Code:2914190090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:173.8±9.0 °C at 760 mmHg
Density:0.8±0.1 g/cm3
Index of Refraction:1.430
PSA:17.07000
Exact Mass:126.104462
LogP:1.97
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1993 3/PG 1
Packing Group:III
Contact us for information like UNII:8K2S58736F chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00792509 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00792509 Use and application,(2E)-5-Methyl-2-hepten-4-one technical grade,usp/ep/jp grade.
Related News: Villages and cities in China have resorted to flying drones with speakers to patrol streets and scold people not wearing masks in public amid the coronavirus outbreak, according to Chinese state media. UNII:8K2S58736F manufacturer They have also voiced frustrations about patients from mainland China hiding their travel and medical history, potentially endangering other patients. UNII:8K2S58736F supplier The GLOW trial doesn’t yet have the answer to that question, but Tendler pointed to encouraging early evidence from the regimen’s phase 2 trial, dubbed CAPTIVATE. Among eight patients who progressed after stopping the fixed-duration combo, six responded to subsequent Imbruvica monotherapy, while the other two didn’t have a response report, according to data presented at the recent American Society of Clinical Oncology annual meeting. UNII:8K2S58736F vendor According to the 2013-2018 New Drug Review Summary report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years. UNII:8K2S58736F factory According to the 2013-2018 New Drug Review Summary report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.
